GINKGO BIOWORKS HOLDINGS, INC. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount of $742.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount · last filed 2025-08-07
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, upward price adjustment, annual amount for the quarter ending 2024-03-31 was $2.67M.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2023 was $9.16M, a 78.72% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2022 was $43.02M, a 272.74% increase from fiscal 2021.
- GINKGO BIOWORKS HOLDINGS, INC. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2021 was $11.54M.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|---|
| 2024-06-30 | $742.00K 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $2.67M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $9.16M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |||
| 2022-12-31 | $43.02M 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $11.54M 10-K · filed 2024-02-29 |